Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.
Francini E, Ou FS, Lazzi S, Petrioli R, Multari AG, Pesola G, Messuti L, Colombo E, Livellara V, Bazzurri S, Cherri S, Miano ST, Wolfe EG, Alberts SR, Hubbard JM, Yoon HH, Francini G. Francini E, et al. Among authors: colombo e. Transl Oncol. 2021 Feb;14(2):100973. doi: 10.1016/j.tranon.2020.100973. Epub 2020 Dec 15. Transl Oncol. 2021. PMID: 33338878 Free PMC article.
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.
Cavalieri S, Platini F, Barretta F, Nuzzolese I, Ottini A, Bergamini C, Resteghini C, Colombo E, Iacovelli NA, Franceschini M, Calareso G, Di Pede P, De Feo G, Gandelli M, Toffolatti L, Guglielmo M, Ripamonti CI, Cosmai L, Licitra L, Alfieri S. Cavalieri S, et al. Among authors: colombo e. Oral Oncol. 2023 Nov;146:106579. doi: 10.1016/j.oraloncology.2023.106579. Epub 2023 Sep 29. Oral Oncol. 2023. PMID: 37778228
NR4A3 fusion molecular profile change pathological diagnosis? A case report.
Pellegrini I, Quattrone P, Dagrada G, Vischioni B, Orlandi E, Colombo E, Licitra L, Locati LD. Pellegrini I, et al. Among authors: colombo e. Oral Oncol. 2022 Aug;131:105964. doi: 10.1016/j.oraloncology.2022.105964. Epub 2022 Jun 19. Oral Oncol. 2022. PMID: 35732102 No abstract available.
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial.
Locati LD, Cavalieri S, Bergamini C, Resteghini C, Colombo E, Calareso G, Mariani L, Quattrone P, Alfieri S, Bossi P, Platini F, Capone I, Licitra L. Locati LD, et al. Among authors: colombo e. J Clin Oncol. 2021 Dec 20;39(36):4061-4068. doi: 10.1200/JCO.21.00468. Epub 2021 Oct 1. J Clin Oncol. 2021. PMID: 34597119 Free PMC article. Clinical Trial.
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions.
Economopoulou P, Pantazopoulos A, Spathis A, Kotsantis I, Kyriazoglou A, Kavourakis G, Zakopoulou R, Chatzidakis I, Anastasiou M, Prevezanou M, Resteghini C, Licitra L, Bergamini C, Colombo E, Caspani F, Denaro N, Vecchio S, Bonomo P, Cossu Rocca M, Bertolini F, Ferrari D, Psyrri A, Bossi P. Economopoulou P, et al. Among authors: colombo e. Cells. 2021 Dec 23;11(1):32. doi: 10.3390/cells11010032. Cells. 2021. PMID: 35011594 Free PMC article.
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies.
Cavalieri S, Filippini DM, Ottini A, Bergamini C, Resteghini C, Colombo E, Lombardo R, Nuzzolese I, Alfieri S, Licitra L, Locati LD. Cavalieri S, et al. Among authors: colombo e. Explor Target Antitumor Ther. 2021;2(6):522-542. doi: 10.37349/etat.2021.00062. Epub 2021 Dec 31. Explor Target Antitumor Ther. 2021. PMID: 36046116 Free PMC article. Review.
775 results